Al-Hajj et al., [11] then described the existence of a subpopulation expressing CD44+/CD24−/ESA+ (ephithelial-specific antigen), which were capable of inducing tumor formation in breast cancer in immunosuppressed mice. Here, CD44 is linked to neoplasm.